Temozolomide for low-grade gliomas: predictive impact of 1p/19q loss on response and outcome.
Kaloshi G, Benouaich-Amiel A, Diakite F, Taillibert S, Lejeune J, Laigle-Donadey F, Renard MA, Iraqi W, Idbaih A, Paris S, Capelle L, Duffau H, Cornu P, Simon JM, Mokhtari K, Polivka M, Omuro A, Carpentier A, Sanson M, Delattre JY, Hoang-Xuan K.
Kaloshi G, et al. Among authors: taillibert s.
Neurology. 2007 May 22;68(21):1831-6. doi: 10.1212/01.wnl.0000262034.26310.a2.
Neurology. 2007.
PMID: 17515545